Phase II study of dasatinib in patients with previously treated malignant mesothelioma (Cancer and Leukemia Group B 30601): a brief report
- Citation:
- J Thorac Oncol vol 7 (4) 755-759
- Year:
- 2012
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 1
- Parents:
- 596
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- A. Z. Dudek H. Pang R. A. Kratzke G. A. Otterson L. Hodgson E. E. Vokes H. L. Kindler
- Networks:
- Study
- CALGB-30601
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: